Regeneron COVID Antibody Treatment Gets Emergency Use Authorization from the FDA
the staff of the Ridgewood blog Ridgewood NJ, according to Johns Hopkins Center for Health Security , the US FDA issued an Emergency Use Authorization (EUA) for another monoclonal antibody treatment for COVID-19. The newest EUA is for a combination therapy using casirivimab and imdevimab, developed by Regeneron Pharmaceuticals, which are monoclonal antibodies that target the receptor binding … Continue reading Regeneron COVID Antibody Treatment Gets Emergency Use Authorization from the FDA
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed